A carregar...

Current status of antigen-specific T-cell immunotherapy for advanced renal-cell carcinoma

In renal-cell carcinoma (RCC), tumor-reactive T-cell responses can occur spontaneously or in response to systemic immunotherapy with cytokines and immune checkpoint inhibitors. Cancer vaccines and engineered T-cell therapies are designed to selectively augment tumor antigen-specific CD8(+) T-cell re...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Hum Vaccin Immunother
Main Authors: Xu, Yuexin, Miller, Chris P., Warren, Edus H., Tykodi, Scott S.
Formato: Artigo
Idioma:Inglês
Publicado em: Taylor & Francis 2021
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC8189101/
https://ncbi.nlm.nih.gov/pubmed/33667140
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/21645515.2020.1870846
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!